Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):239-52. Epub 2007 Sep 21.

Towards a dengue vaccine: progress to date and remaining challenges.

Source

Sanofi pasteur, 1541 Avenue Marcel Merieux, 69280 Marcy L'Etoile, France.

Abstract

The increased incidence and extended geographical reach of Dengue virus over the past two decades have made the development of an effective vaccine an international urgency. Various strategies are being pursued, including live, vectored and killed/recombinant preparations. For all approaches, the challenge is to induce a broad durable immune response against all four serotypes of Dengue virus simultaneously whilst avoiding the possible exacerbation of risk of developing the severe forms of disease through incomplete or modified responses. This review presents the current state of knowledge and discusses the challenges of further clinical development.

PMID:: 17889365; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Dengue - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes. [Vaccine. 2009]
Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
Ramanathan MP, Kuo YC, Selling BH, Li Q, Sardesai NY, Kim JJ, Weiner DB. Vaccine. 2009 Oct 30; 27(46):6444-53. Epub 2009 Jul 4.
An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity. [Vaccine. 2009]
An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S, Pilankatta R, Khanna N, Swaminathan S. Vaccine. 2009 Oct 9; 27(43):6011-21. Epub 2009 Aug 7.
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. [J Virol. 2008]
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.
Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K. J Virol. 2008 Jul; 82(14):6927-34. Epub 2008 May 14.
Review Progress towards a dengue vaccine. [Lancet Infect Dis. 2009]
Review Progress towards a dengue vaccine.
Webster DP, Farrar J, Rowland-Jones S. Lancet Infect Dis. 2009 Nov; 9(11):678-87.
Review Dengue vaccine candidates in development. [Curr Top Microbiol Immunol. 2010]
Review Dengue vaccine candidates in development.
Durbin AP, Whitehead SS. Curr Top Microbiol Immunol. 2010; 338:129-43.

See reviews... See all...

Cited by 2 PubMed Central articles

Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2. [Immune Netw. 2011]
Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2.
George JA, Eo SK. Immune Netw. 2011 Oct; 11(5):268-80. Epub 2011 Oct 31.
Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence. [J Virol. 2011]
Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.
Stein DA, Perry ST, Buck MD, Oehmen CS, Fischer MA, Poore E, Smith JL, Lancaster AM, Hirsch AJ, Slifka MK, et al. J Virol. 2011 Oct; 85(19):10154-66. Epub 2011 Jul 27.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Towards a dengue vaccine: progress to date and remaining challenges.
Towards a dengue vaccine: progress to date and remaining challenges.
Comp Immunol Microbiol Infect Dis. 2008 Mar ;31(2-3):239-52. Epub 2007 Sep 21 .

PubMed
Wegener granulomatosis with spleen infarction: case report and review of the lit...
Wegener granulomatosis with spleen infarction: case report and review of the literature.
Semin Arthritis Rheum. 2008 Apr ;37(5):328-33. Epub 2007 Sep 21 .

PubMed
IgE food sensitization in infants with eczema attending a dermatology department...
IgE food sensitization in infants with eczema attending a dermatology department.
J Pediatr. 2007 Oct ;151(4):359-63. Epub 2007 Aug 6 .

PubMed
Lung transplantation for idiopathic pulmonary fibrosis.
Lung transplantation for idiopathic pulmonary fibrosis.
Ann Thorac Surg. 2007 Oct ;84(4):1121-8.

PubMed
Structural characterization of zinc-deficient human superoxide dismutase and imp...
Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.
J Mol Biol. 2007 Nov 2 ;373(4):877-90. Epub 2007 Aug 2 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: